Cargando…
1609 Plasma markers of immune activation likely reflect related but distinct processes of cellular immune activation in HIV-infected persons before and after suppression of viremia by antiretroviral therapy: ACTG 5260
Autores principales: | Kelesidis, Theodoros, Moser, Carlee, Mccomsey, Grace A., Brown, Todd, Ribaudo, Heather, Tran, Thuy Tien T, Yang, Otto, Stein, James, Currier, Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5782323/ http://dx.doi.org/10.1093/ofid/ofu052.1155 |
Ejemplares similares
-
Changes in Insulin Resistance After Initiation of Raltegravir or Protease Inhibitors With Tenofovir-Emtricitabine: AIDS Clinical Trials Group A5260s
por: Dirajlal-Fargo, Sahera, et al.
Publicado: (2016) -
1564 Duration of Viral Suppression and objectively measured Antiretroviral Adherence as predictors of rebound Viremia in South Western Uganda
por: Musinguzi, Nicholas
Publicado: (2014) -
1327 Factors associated with optimizing empiric antibiotic therapy in six hospitals
por: Morgan, Daniel, et al.
Publicado: (2014) -
1617 Safety, Tolerability, and Antiretroviral Activity of Raltegravir in HIV-1 Infected Russian Children and Adolescents – a 24 Week Study
por: Teppler, Hedy, et al.
Publicado: (2014) -
1573 Use of protease inhibitors is associated with higher selenium levels in treated HIV infection
por: Kumar, Jessica, et al.
Publicado: (2014)